Proton therapy in the treatment of hepatocellular carcinoma

Liver cancer represents one of the most common causes of death from cancer worldwide. Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancers. Among local therapies, evidence regarding the use of radiation therapy is growing. Proton therapy currently represents the most advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Dionisi, Francesco, Scartoni, Daniele, Fracchiolla, Francesco, Giacomelli, Irene, Siniscalchi, Benedetta, Goanta, Lucia, Cianchetti, Marco, Sanguineti, Giuseppe, Brolese, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393743/
https://www.ncbi.nlm.nih.gov/pubmed/36003769
http://dx.doi.org/10.3389/fonc.2022.959552
Descripción
Sumario:Liver cancer represents one of the most common causes of death from cancer worldwide. Hepatocellular carcinoma (HCC) accounts for 90% of all primary liver cancers. Among local therapies, evidence regarding the use of radiation therapy is growing. Proton therapy currently represents the most advanced radiation therapy technique with unique physical properties which fit well with liver irradiation. Here, in this review, we aim to 1) illustrate the rationale for the use of proton therapy (PT) in the treatment of HCC, 2) discuss the technical challenges of advanced PT in this disease, 3) review the major clinical studies regarding the use of PT for HCC, and 4) analyze the potential developments and future directions of PT in this setting.

Ejemplares similares